Zolbetuximab & Nivolumab: CLDN18.2+ Gastric Cancer Trial
Promising Drug Combination Shows Efficacy in Advanced Gastric Cancer In a significant development for patients battling advanced gastric cancer, a novel treatment approach combining zolbetuximab, mFOLFOX6 chemotherapy, and nivolumab has demonstrated encouraging results in a recent clinical trial. The findings, stemming from cohort 4 of the ILUSTRO study, offer renewed hope for individuals with CLDN18.2-positive, … Read more